>>Focus Going Forward
- Increase global presence with acquisition of TomoTherapy.
- Reduce overall operating expenses across Accuray and TomoTherapy by $25 million.
- Make improvements to TomoTherapy system via engineering talent.
Showing posts with label accuray. Show all posts
Showing posts with label accuray. Show all posts
Wednesday, May 4, 2011
Robotic Radiosurgery: Long R&D Road Pays Off
from www.mddionline.com:
>>Focus Going Forward
>>Focus Going Forward
Thursday, April 14, 2011
Wednesday, April 13, 2011
Soleil Securities Raises Price Target Accuray
from www.streetinsider.com:
>>Soleil Securities is reiterating its Buy rating on shares of Accuray (Nasdaq: ARAY) and is rasing its price target from $10 to $11 as it believes that the company will benefit from Alliance Imaging (NYSE: AIQ) acquirering U.S. Radiosurgery's CyberKnife business.
Alliance obtained 7 additional CyberKnife centers which brings that company's total to 13 and makes Alliance the leading company in CyberKnife systems.
>>Soleil Securities is reiterating its Buy rating on shares of Accuray (Nasdaq: ARAY) and is rasing its price target from $10 to $11 as it believes that the company will benefit from Alliance Imaging (NYSE: AIQ) acquirering U.S. Radiosurgery's CyberKnife business.
Alliance obtained 7 additional CyberKnife centers which brings that company's total to 13 and makes Alliance the leading company in CyberKnife systems.
Friday, March 25, 2011
Austin CyberKnife
from impactnews.com:
>The Seton Family of Hospitals opened Austin CyberKnife on March 7 at the UMC Brackenridge campus, 1400 N. I-35. CyberKnife is used primarily to treat brain tumors and reach tumors in other parts of the body, including the lungs, pancreas and spine.
>The Seton Family of Hospitals opened Austin CyberKnife on March 7 at the UMC Brackenridge campus, 1400 N. I-35. CyberKnife is used primarily to treat brain tumors and reach tumors in other parts of the body, including the lungs, pancreas and spine.
Monday, March 14, 2011
Jefferies Raises Price Target on Accuray (ARAY)
from www.streetinsider.com:
>>Jefferies is maintaining their Buy rating on shares of Accuray (NASDAQ: ARAY) following their recent announcement on their plans to acquire TomoTherapy Incorporate.
>>Jefferies is maintaining their Buy rating on shares of Accuray (NASDAQ: ARAY) following their recent announcement on their plans to acquire TomoTherapy Incorporate.
Sunday, March 13, 2011
Pet-CT Technology with the Cyberknife
from www.wsav.com:
>>Construction to house the only CyberKnife in the region is also underway.
The robotic CyberKnife treats difficult tumors and can automatically adjust the patent's movement.
"For instance if you had a brain tumor that was near the optic nerve and you didn't want to injure it with radiation therapy because it's right next to the brain tumor this would allow you to give it so precisely 3 dimensional stereotactically. So that's the beauty. it's magic."
The new technology is part of a 6 million dollars is upgrades for patients at the Lewis Cancer Pavilion.
>>Construction to house the only CyberKnife in the region is also underway.
The robotic CyberKnife treats difficult tumors and can automatically adjust the patent's movement.
"For instance if you had a brain tumor that was near the optic nerve and you didn't want to injure it with radiation therapy because it's right next to the brain tumor this would allow you to give it so precisely 3 dimensional stereotactically. So that's the beauty. it's magic."
The new technology is part of a 6 million dollars is upgrades for patients at the Lewis Cancer Pavilion.
Friday, March 11, 2011
Soleil upgraded Accuray
from Benzinga:
>>Soleil upgraded Accuray Incorporated (NASDAQ: ARAY) from “sell” to “buy.” ARAY's shares closed at $8.40 yesterday. Accuray's trailing-twelve-month revenue is $206.04 billion.
>>Soleil upgraded Accuray Incorporated (NASDAQ: ARAY) from “sell” to “buy.” ARAY's shares closed at $8.40 yesterday. Accuray's trailing-twelve-month revenue is $206.04 billion.
Thursday, March 10, 2011
Exclusive: Accuray, TomoTherapy chiefs explain merger
from www.dotmed.com:
>>But in conversation with DOTmed News, both Accuray CEO and President Euan S. Thomson and TomoTherapy CEO Dr. Frederick A. Robertson have hopes the transaction will have an "emergent" property greater than the sum of its parts.
Both men argue the combined companies will streamline overhead expenses and also combine technological know-how to make TomoTherapy's previously struggling service business break even by the end of the year. They also see benefit to what they're viewing as a melding of Silicon Valley marketing and Madison's engineering strengths.
>>But in conversation with DOTmed News, both Accuray CEO and President Euan S. Thomson and TomoTherapy CEO Dr. Frederick A. Robertson have hopes the transaction will have an "emergent" property greater than the sum of its parts.
Both men argue the combined companies will streamline overhead expenses and also combine technological know-how to make TomoTherapy's previously struggling service business break even by the end of the year. They also see benefit to what they're viewing as a melding of Silicon Valley marketing and Madison's engineering strengths.
Tuesday, March 8, 2011
CK vs TOMO
from the yahoo MB, by lamb:
>>From a strictly MEDICAL viewpoint, CK and TOMO are not competitors but compliment each other. CK is an SRS tool and TOMO is terrific for IMRT. Yes these roles can be reversed in some cases but the tech is not designed for this and is unwieldly (eg - using CK for a protracted course of IMRT). TOMO is not an "inferior gantry-based radiation sprayer". TOMO is a fabulous innovation in radiation delivery in which radiation is delivered in thousands of beamlets in a helical pattern like a CT, which mitigates a good deal of the disadvantage in delivering beams in 2D only. Yes I know there has been a good deal of down time and service costs with the initial TOMO units. IMO TOMO is superior to gantry LINACs for IMRT, though this advantage is less than that of CK over gantry LINACs for SRS.
This is the medical aspect. For the financial metrics I turn to this board. My intuition tells me ARAY would have been better off concentrating on CK and SRS, where their technological advantage is greater. Discontinuing TOMO would help Var more than ARAY. And I'm willing to stand corrected by engineers, but it is not obvious to me why ARAY service people who have worked on the miniature Linac and KUKA robot would have particular skills over others working on a helical LINAC like TOMO, completely different technology.
>>From a strictly MEDICAL viewpoint, CK and TOMO are not competitors but compliment each other. CK is an SRS tool and TOMO is terrific for IMRT. Yes these roles can be reversed in some cases but the tech is not designed for this and is unwieldly (eg - using CK for a protracted course of IMRT). TOMO is not an "inferior gantry-based radiation sprayer". TOMO is a fabulous innovation in radiation delivery in which radiation is delivered in thousands of beamlets in a helical pattern like a CT, which mitigates a good deal of the disadvantage in delivering beams in 2D only. Yes I know there has been a good deal of down time and service costs with the initial TOMO units. IMO TOMO is superior to gantry LINACs for IMRT, though this advantage is less than that of CK over gantry LINACs for SRS.
This is the medical aspect. For the financial metrics I turn to this board. My intuition tells me ARAY would have been better off concentrating on CK and SRS, where their technological advantage is greater. Discontinuing TOMO would help Var more than ARAY. And I'm willing to stand corrected by engineers, but it is not obvious to me why ARAY service people who have worked on the miniature Linac and KUKA robot would have particular skills over others working on a helical LINAC like TOMO, completely different technology.
Market Share Implications of Accuracy's TomoTherapy Acquisition
from Benzinga:
>>Citi released a report today which discusses the implications of Accuracy's (NASDAQ: ARAY) acquisition of TomoTherapy (NASDAQ: TOMO) and its effects on Varian Medical Systems' (NYSE: VAR) market share. While the deal will allow ARAY to expand from radiosurgery into radiotherapy, Citi analysts do not believe this will have near-term impacts on VAR's position in the radiation oncology market. This is due in part to VAR's relatively large market share of 55% compared to the single-digit shares of ARAY and TOMO.
>>Citi released a report today which discusses the implications of Accuracy's (NASDAQ: ARAY) acquisition of TomoTherapy (NASDAQ: TOMO) and its effects on Varian Medical Systems' (NYSE: VAR) market share. While the deal will allow ARAY to expand from radiosurgery into radiotherapy, Citi analysts do not believe this will have near-term impacts on VAR's position in the radiation oncology market. This is due in part to VAR's relatively large market share of 55% compared to the single-digit shares of ARAY and TOMO.
Analysts further note that despite TOMO's recent underperformance, the newly combined organization should be profitable in future quarters. ARAY has expanded its market share but is still trailing key competitors such as Varian, Elekta, and Siemens. Analysts also believe that the ARAY deal is the best possible outcome for TOMO.
NJ's 7th CK at Community Medical Center in Toms River
from the IV MB, by yyy60.
>>http://jobs.nj.com/careers/jobsearch/detail?jobId=35438424
Physician Services Representative - Cyberknife Project
Employer: Community Medical Center
Location: Toms River, NJ
Last Updated: 03/08/2011
Job Code: T452828
Community Medical Center is a 587-bed, fully accredited acute care hospital, offering area residents world-class medical treatment with the comforts of hometown care. Opened in 1961, CMC has evolved into the state's largest non-teaching hospital and Ocean County's largest and most active healthcare facility
The Physician Services Representative will oversee sales and marketing of the Cyberknife Project.
https://www3.apply2jobs.com/alliancehealthcareservices-us/ProfExt/index.cfm?fuseaction=mExternal.showJob&RID=1106&CurrentPage=9&sid=24
Job Title: Cyberknife Nurse Coordinator
Position Type: Full Time - (36-40 HRS)
....
State: New Jersey
City: Toms River
Description: Performs a wide variety of duties involving the clinical care of patients receiving Cyberknife program treatment. Works with physicians and staff in providing care to patients and coordinates all aspects of the Cyberknife program including accepting referrals, educating patients and families, scheduling tests and treatments.
>>http://jobs.nj.com/careers/jobsearch/detail?jobId=35438424
Physician Services Representative - Cyberknife Project
Employer: Community Medical Center
Location: Toms River, NJ
Last Updated: 03/08/2011
Job Code: T452828
Community Medical Center is a 587-bed, fully accredited acute care hospital, offering area residents world-class medical treatment with the comforts of hometown care. Opened in 1961, CMC has evolved into the state's largest non-teaching hospital and Ocean County's largest and most active healthcare facility
The Physician Services Representative will oversee sales and marketing of the Cyberknife Project.
https://www3.apply2jobs.com/alliancehealthcareservices-us/ProfExt/index.cfm?fuseaction=mExternal.showJob&RID=1106&CurrentPage=9&sid=24
Job Title: Cyberknife Nurse Coordinator
Position Type: Full Time - (36-40 HRS)
....
State: New Jersey
City: Toms River
Description: Performs a wide variety of duties involving the clinical care of patients receiving Cyberknife program treatment. Works with physicians and staff in providing care to patients and coordinates all aspects of the Cyberknife program including accepting referrals, educating patients and families, scheduling tests and treatments.
Friday, March 4, 2011
First Cyberknife in Beijing
from the IV MB, by yyy60:
>>** This news is bullish. It said "the opening of this representative of the official opening of the Chinese market".
http://money.chinatimes.com/newmoney/realtime/newscontent.aspx?NewsSN=000301001080
** translated from Chinese **
2011-03-01 14:47 Times News (Taiwan)
People's Liberation Army 302 Hospital in Beijing the whole of China's first fourth-generation CyberKnife Cancer Center opened in the end of February, KY plant Emerging medical material holding together the rich medical (4745).
Said the product of its agents, Chinese PLA 302 Hospital is the only three A-level infectious disease, liver disease hospital, the opening of this representative of the official opening of the Chinese market, with symbolic significance and will actively enter the country more than a thousand The top three hospital market, is expected this year, agency business from tumor equipment accounted for 7% of revenue last year, jumped 2-3 in one fell swoop into.
>>** This news is bullish. It said "the opening of this representative of the official opening of the Chinese market".
http://money.chinatimes.com/newmoney/realtime/newscontent.aspx?NewsSN=000301001080
** translated from Chinese **
2011-03-01 14:47 Times News (Taiwan)
People's Liberation Army 302 Hospital in Beijing the whole of China's first fourth-generation CyberKnife Cancer Center opened in the end of February, KY plant Emerging medical material holding together the rich medical (4745).
Said the product of its agents, Chinese PLA 302 Hospital is the only three A-level infectious disease, liver disease hospital, the opening of this representative of the official opening of the Chinese market, with symbolic significance and will actively enter the country more than a thousand The top three hospital market, is expected this year, agency business from tumor equipment accounted for 7% of revenue last year, jumped 2-3 in one fell swoop into.
Wednesday, February 16, 2011
Robotic radiosurgery expanded to breast cancer
from www.healthimaging.com:
>>The University of Texas Southwestern Medical Center has completed the first of 45 planned post-lumpectomy high-beam radiation treatment as part of a clinical trial to assess the effectiveness of the focused, shorter-course treatment.
The Dallas-based University of Texas Southwestern Medical Center trial will investigate Accuray’s CyberKnife System, already in use for head and neck radiation oncology procedures, for use in women with localized early-stage breast cancer following successful lumpectomies.
...
Led by Robert Timmerman, MD, professor of radiation oncology at UT Southwestern, the researchers will evaluate patients over the next 10 years for tumor recurrences as well as cosmetic changes, for which the system is purported to deliver improved results.
>>The University of Texas Southwestern Medical Center has completed the first of 45 planned post-lumpectomy high-beam radiation treatment as part of a clinical trial to assess the effectiveness of the focused, shorter-course treatment.
The Dallas-based University of Texas Southwestern Medical Center trial will investigate Accuray’s CyberKnife System, already in use for head and neck radiation oncology procedures, for use in women with localized early-stage breast cancer following successful lumpectomies.
...
Led by Robert Timmerman, MD, professor of radiation oncology at UT Southwestern, the researchers will evaluate patients over the next 10 years for tumor recurrences as well as cosmetic changes, for which the system is purported to deliver improved results.
Wednesday, February 9, 2011
Tennessee's 5th CK at Baptist Memorial Hospital in Memphis
from the IV MB, by yyy60:
>>** Saint Francis Hospital in Memphis is also interested to acq a CK. The current status is unknown.
http://www.commercialappeal.com/news/2011/feb/09/baptist-memorial-memphis-adding-75m-cyberknife-fal/
Baptist Memorial in Memphis is adding $7.5M CyberKnife this fall
By Toby Sells
Memphis Commercial Appeal, Memphis TN
February 9, 2011
Baptist Memorial Health Care Corp. is buying a $7.5 million robotic “knife” that will allow its physicians to more accurately pinpoint and remove cancer tumors.
The Tennessee Health Services and Development Agency gave Baptist the green light to buy Accuray’s CyberKnife Robotic Radiosurgery System earlier this month.
The CyberKnife will be installed at the Baptist Center for Cancer Care on the Baptist Memorial Hospital-Memphis campus on Walnut Grove.
The CyberKnife’s “blade” is a precision-guided beam of radiation that is shot into a patient’s body to remove tumors from numerous spots such as the pancreas, liver, prostate, brain and spine.
...
Saint Francis Hospital-Memphis received approval to buy a CyberKnife in 2008 but has not yet made the purchase. Saint Francis vice president Marilynn Robinson said the approval came with a three-year window to make the purchase and the hospital intends to have one installed before that window closes in September.
The hospital was looking to jointly purchase CyberKnife with a physician group, Robinson said. The delay in making the purchase came as the hospital and the group tried to work out the legalities of the partnership, though they couldn’t make it work, she said.
Baptist made the purchase on the medical guidance of Dr. Jason Weaver, a neurosurgeon with Semmes Murphey Neurologic and Spine Institute who is also on Baptist’s medical staff. The system will allow Baptist to expand its current treatment capability, which now has a wait time of a week or more.
“We felt this was a natural progression to an already robust stereotactic radiosurgery program,” Weaver said. “It’s a natural addition of technology to grow our program.”
>>** Saint Francis Hospital in Memphis is also interested to acq a CK. The current status is unknown.
http://www.commercialappeal.com/news/2011/feb/09/baptist-memorial-memphis-adding-75m-cyberknife-fal/
Baptist Memorial in Memphis is adding $7.5M CyberKnife this fall
By Toby Sells
Memphis Commercial Appeal, Memphis TN
February 9, 2011
Baptist Memorial Health Care Corp. is buying a $7.5 million robotic “knife” that will allow its physicians to more accurately pinpoint and remove cancer tumors.
The Tennessee Health Services and Development Agency gave Baptist the green light to buy Accuray’s CyberKnife Robotic Radiosurgery System earlier this month.
The CyberKnife will be installed at the Baptist Center for Cancer Care on the Baptist Memorial Hospital-Memphis campus on Walnut Grove.
The CyberKnife’s “blade” is a precision-guided beam of radiation that is shot into a patient’s body to remove tumors from numerous spots such as the pancreas, liver, prostate, brain and spine.
...
Saint Francis Hospital-Memphis received approval to buy a CyberKnife in 2008 but has not yet made the purchase. Saint Francis vice president Marilynn Robinson said the approval came with a three-year window to make the purchase and the hospital intends to have one installed before that window closes in September.
The hospital was looking to jointly purchase CyberKnife with a physician group, Robinson said. The delay in making the purchase came as the hospital and the group tried to work out the legalities of the partnership, though they couldn’t make it work, she said.
Baptist made the purchase on the medical guidance of Dr. Jason Weaver, a neurosurgeon with Semmes Murphey Neurologic and Spine Institute who is also on Baptist’s medical staff. The system will allow Baptist to expand its current treatment capability, which now has a wait time of a week or more.
“We felt this was a natural progression to an already robust stereotactic radiosurgery program,” Weaver said. “It’s a natural addition of technology to grow our program.”
U of Tennessee: CyberKnife radiosurgery 5-year report released
from the IV MB, by yyy60:
>>Tuesday, February 08, 2011
The Brain and Spine Institute and Cancer Institute released the 5-year report for CyberKnife radiosurgery that features a clear overview of CyberKnife, statistics, treatment methods and patient treatment successes. In 2005, The University of Tennessee Medical Center became only the 23rd site in the United States to offer CyberKnife Stereotactic Radiosurgery. Over the first five years of operation, the physicians and staff of the CyberKnife Center provided more than 1,600 treatments to patients in our region and throughout the Southeast. This technology continues to offer options for patients facing complex diseases and conditions.
Since treating the first patient in January 2005, research studies published in peer reviewed literature continue to validate CyberKnife as an effective tool in treating both malignant and benign conditions. Based on this research, the use of radiosurgery is expanding and becoming standard of care treatment for many conditions. Advancements in CyberKnife equipment and software also continue to evolve, leading to improved and faster delivery of treatments.
Read the full CyberKnife radiosurgery 5-year report.
http://www.utmedicalcenter.org/imagesLive/Users/NEWS/2011 News/0211/UTMC CyberKnife Annual Report_011711.pdf
>>Tuesday, February 08, 2011
The Brain and Spine Institute and Cancer Institute released the 5-year report for CyberKnife radiosurgery that features a clear overview of CyberKnife, statistics, treatment methods and patient treatment successes. In 2005, The University of Tennessee Medical Center became only the 23rd site in the United States to offer CyberKnife Stereotactic Radiosurgery. Over the first five years of operation, the physicians and staff of the CyberKnife Center provided more than 1,600 treatments to patients in our region and throughout the Southeast. This technology continues to offer options for patients facing complex diseases and conditions.
Since treating the first patient in January 2005, research studies published in peer reviewed literature continue to validate CyberKnife as an effective tool in treating both malignant and benign conditions. Based on this research, the use of radiosurgery is expanding and becoming standard of care treatment for many conditions. Advancements in CyberKnife equipment and software also continue to evolve, leading to improved and faster delivery of treatments.
Read the full CyberKnife radiosurgery 5-year report.
http://www.utmedicalcenter.org/imagesLive/Users/NEWS/2011 News/0211/UTMC CyberKnife Annual Report_011711.pdf
Tuesday, February 8, 2011
Houston VA Hospital Offering CK
from the IV MB, by yyy60:
>>HOUSTON, TX - Always on the forefront of innovative treatments and technologies, the Michael E. DeBakey VA Medical Center (MEDVAMC) now provides Veterans a targeted, painless alternative to open surgery and a medical option for certain inoperable tumors.
The CyberKnife®, an impressive-looking machine resembling a giant robot with a multi-jointed arm that pivots, twists, and turns, can treat tumors anywhere in the body with radiosurgery.
Poised above the patient, who is fully clothed and awake on a table, the device’s giant arm whirs above, beside, then under the tumor site, delivering hundreds of beams of radiation to the tumor with pinpoint accuracy.
"The flexible arm allows for precisely targeted radiation delivery and can reach areas of the body that are untreatable with other, more limited radiation-delivery systems," said Angela Zhu, M.D., acting Radiotherapy Section chief.
>>HOUSTON, TX - Always on the forefront of innovative treatments and technologies, the Michael E. DeBakey VA Medical Center (MEDVAMC) now provides Veterans a targeted, painless alternative to open surgery and a medical option for certain inoperable tumors.
The CyberKnife®, an impressive-looking machine resembling a giant robot with a multi-jointed arm that pivots, twists, and turns, can treat tumors anywhere in the body with radiosurgery.
Poised above the patient, who is fully clothed and awake on a table, the device’s giant arm whirs above, beside, then under the tumor site, delivering hundreds of beams of radiation to the tumor with pinpoint accuracy.
"The flexible arm allows for precisely targeted radiation delivery and can reach areas of the body that are untreatable with other, more limited radiation-delivery systems," said Angela Zhu, M.D., acting Radiotherapy Section chief.
Thursday, February 3, 2011
12 Advances in Medical Robotics: #4 is the CyberKnife System
12 Advances In Medical Robotics -- InformationWeek
www.informationweek.com
www.informationweek.com
Robots play a critical -- and growing -- role in modern medicine, from training the next generation of doctors, dentists, and nurses, to comforting and protecting elderly patients in the early stages of dementia.
Wednesday, February 2, 2011
Mexico's 1st Cyberknife at Instituto Mexicano del Seguro Social
from the IV MB, by yyy60:
>>Who was the best gift to Rafael Moreno Valle was Daniel Karam Toureh.
The director of the Instituto Mexicano del Seguro Social (IMSS) overcame a jam than a quarter of a century and completed a nearly 200-bed hospital in Puebla.
Yesterday we put into service.
Added to 60 new medical units, with consequent recruitment of doctors, nurses, technicians and administrative staff, put into service in less than two years.
http://quadratintabasco.com.mx/noticias/nota,21886/
>>Who was the best gift to Rafael Moreno Valle was Daniel Karam Toureh.
The director of the Instituto Mexicano del Seguro Social (IMSS) overcame a jam than a quarter of a century and completed a nearly 200-bed hospital in Puebla.
Yesterday we put into service.
Added to 60 new medical units, with consequent recruitment of doctors, nurses, technicians and administrative staff, put into service in less than two years.
http://quadratintabasco.com.mx/noticias/nota,21886/
Monday, January 31, 2011
Subscribe to:
Posts (Atom)
Posts
